论文部分内容阅读
目的探讨连续性静脉-静脉血液滤过(continuous venovenous hemofihration,CVVH)对Ⅰ型心肾综合征患者的顽固性心衰及渐进性肾衰的缓解作用。方法采用CVVH的方法治疗Ⅰ型心肾综合征患者20例(血滤组),观察其治疗前后心功能及各项临床指标的变化,并与单纯应用药物治疗心肾综合征患者(对照组)作对比。结果血滤组患者治疗后心功能及临床不适症状等均明显改善,而对照组则变化不明显,甚至加重。结论 CVVH能够显著改善Ⅰ型心肾综合征患者的心、肾功能,且疗效确切,无明显不良反应。
Objective To investigate the effect of continuous venovenous hemofihration (CVVH) on refractory heart failure and progressive renal failure in patients with type I heart-kidney syndrome. Methods The CVVH method was used to treat 20 patients with type Ⅰ heart-kidney syndrome (FFA). The changes of cardiac function and clinical indexes before and after treatment were observed. Compared with the patients treated with simple drug therapy for heart and kidney syndrome (control group) For comparison. Results In patients with hemofiltration, heart function and clinical symptoms were significantly improved after treatment, while the control group did not change significantly or even worse. Conclusion CVVH can significantly improve the heart and kidney function in patients with type Ⅰ heart-kidney syndrome, and the curative effect is correct without obvious adverse reactions.